Stephanie Hsieh

Stephanie Hsieh was appointed as a director of the Company and the Bank effective July 29, 2022. Ms. Hsieh joined Biocom California, the state’s leading non-profit trade association for the life science industry, as Executive Director of the Los Angeles region in 2020. Prior to Biocom California, she co-founded Meditope Biosciences, Inc., a privately-held, preclinical-stage oncology company, where she served as CEO from 2021 – 2020 and where she currently serves as a non-executive director. Ms. Hsieh began her career as an intellectual property attorney, specializing in patent prosecution and litigation, and actively practiced law for a combined fifteen years. She served in a variety of legal and business roles in the biotechnology and biopharmaceutical industries, including as a senior executive at Impax Laboratories, Inc. from 2007-2011.

Ms. Hsieh is active in the community, serving on the Board of Directors of several non-profits. She was recognized in 2021 and 2022 by the LA Business Journal as one of Los Angeles’ “most influential leaders.” She graduated magna cum laude and Phi Beta Kappa from Wellesley College, as a Harlan Fiske Stone Scholar from Columbia Law School, and holds an MBA from Stanford Business School.